For the quarter ended September 2025, Encompass Health (EHC Quick QuoteEHC - Free Report) reported revenue of $1.48 billion, up 9.4% over the same period last year. EPS came in at $1.23, compared to $1.03 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $1.48 billion, representing a surprise of +0.05%. The company delivered an EPS surprise of +3.36%, with the consensus EPS estimate being $1.19.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Encompass Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Net patient revenue per discharge: $21,679.00 compared to the $21,612.91 average estimate based on two analysts.
• Discharges: 65,839 compared to the 66,576 average estimate based on two analysts.
• Net Operating Revenues- Net patient revenue- Inpatient: $1.43 billion versus $1.44 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +8.4% change.
• Net Operating Revenues- Net patient revenue- Outpatient and other: $50.2 million compared to the $42.58 million average estimate based on two analysts. The reported number represents a change of +44.3% year over year.

View all Key Company Metrics for Encompass Health here>>>

Shares of Encompass Health have returned -5.5% over the past month versus the Zacks S&P 500 composite's +2.1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.